{"title":"Testosterone Therapy in Men with Biochemical Recurrence and Metastatic Prostate Cancer: Initial Observations","authors":"A. Morgentaler, A. Abello, G. Bubley","doi":"10.1089/ANDRO.2021.0001","DOIUrl":null,"url":null,"abstract":"Introduction: Although prostate cancer (PCa) has long been considered an absolute contraindication for testosterone therapy (TTh), growing literature suggests TTh may be safely offered to men with ...","PeriodicalId":72197,"journal":{"name":"Androgens: clinical research and therapeutics","volume":"3 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Androgens: clinical research and therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/ANDRO.2021.0001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 9
Abstract
Introduction: Although prostate cancer (PCa) has long been considered an absolute contraindication for testosterone therapy (TTh), growing literature suggests TTh may be safely offered to men with ...